Literature DB >> 7577492

Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.

E C Abeln1, N J Kuipers-Dijkshoorn, E M Berns, S C Henzen-Logmans, G J Fleuren, C J Cornelisse.   

Abstract

Detection of loss of heterozygosity (LOH) and DNA flow cytometry (FCM) were used to trace the origin of bilateral ovarian cancer from 16 patients. From each tumour the DNA index (DI) and LOH patterns for chromosomes 1, 3, 6, 11, 17, 18, 22 and X were determined with 36 microsatellite markers. Formalin-fixed, paraffin-embedded as well as frozen specimens were used. Flow cytometric cell sorting was used to enrich tumour cells for polymerase chain reaction (PCR)-driven LOH analysis. Analysis of the LOH data showed that in 12 of the 16 cases concordance was observed for all informative markers, namely retention of heterozygosity (ROH) or loss of identical alleles in both tumour samples. In four cases discordant LOH patterns were observed. In two cases the discordant LOH was found for one of the chromosomes tested while other LOH patterns clearly indicated a unifocal origin. This suggests limited clonal divergence. In the other two cases all LOH patterns were discordant, most likely indicating an independent origin. The number of chromosomes showing LOH ranged from 0 to 6. Comparison of DNA FCM and the LOH data showed that the latter technique has a higher sensitivity for the detection of a unifocal origin. In 14/16 cases evidence was found for a unifocal origin, while in two cases clonal divergence was found at LOH level and in two other cases clonal divergence at DNA ploidy level. In 12 cases the complete observed allelotype had developed before the formation of metastases, including the two cases showing a large DNA ploidy difference.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577492      PMCID: PMC2033953          DOI: 10.1038/bjc.1995.510

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  Genomic imprinting and gene activation in cancer.

Authors:  A P Feinberg
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

2.  Human epithelial ovarian cancer allelotype.

Authors:  W Cliby; S Ritland; L Hartmann; M Dodson; K C Halling; G Keeney; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

3.  Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

Authors:  B A Bonsing; P Devilee; A M Cleton-Jansen; N Kuipers-Dijkshoorn; G J Fleuren; C J Cornelisse
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

4.  Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.

Authors:  H Saito; J Inazawa; S Saito; F Kasumi; S Koi; S Sagae; R Kudo; J Saito; K Noda; Y Nakamura
Journal:  Cancer Res       Date:  1993-07-15       Impact factor: 12.701

5.  Allelic loss in ovarian cancer.

Authors:  T L Yang-Feng; H Han; K C Chen; S B Li; E B Claus; M L Carcangiu; S K Chambers; J T Chambers; P E Schwartz
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

6.  Prognostic factors in well-differentiated early-stage epithelial ovarian cancer.

Authors:  J A Schueler; C J Cornelisse; J Hermans; J B Trimbos; M E van der Burg; G J Fleuren
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

7.  Detection of the t(14;18) translocation in frozen and formalin-fixed tissue.

Authors:  J Limpens; M Beelen; R Stad; M Haverkort; J H van Krieken; G J van Ommen; P M Kluin
Journal:  Diagn Mol Pathol       Date:  1993-06

8.  Polymerase chain reaction allelotyping of human ovarian cancer.

Authors:  R J Osborne; V Leech
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

9.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

10.  PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.

Authors:  N A Gruis; E C Abeln; A F Bardoel; P Devilee; R R Frants; C J Cornelisse
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

View more
  4 in total

1.  Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.

Authors:  HanByoul Cho; Eun Suk Kang; Soon Won Hong; Youn Jin Oh; Sun Mi Choi; Sang Wun Kim; Sung Hoon Kim; Young Tae Kim; Kyoung Sun Lee; Yang Kyu Choi; Jae-Hoon Kim
Journal:  Mol Cell Biochem       Date:  2008-08-06       Impact factor: 3.396

2.  Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.

Authors:  Nathalie L G Sieben; Sandra M Kolkman-Uljee; Adrienne M Flanagan; Saskia le Cessie; Anne-Marie Cleton-Jansen; Cees J Cornelisse; Gert Jan Fleuren
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

3.  Genomic and transcriptomic plasticity in treatment-naive ovarian cancer.

Authors:  Marlous Hoogstraat; Mirjam S de Pagter; Geert A Cirkel; Markus J van Roosmalen; Timothy T Harkins; Karen Duran; Jennifer Kreeftmeijer; Ivo Renkens; Petronella O Witteveen; Clarence C Lee; Isaac J Nijman; Tanisha Guy; Ruben van 't Slot; Trudy N Jonges; Martijn P Lolkema; Marco J Koudijs; Ronald P Zweemer; Emile E Voest; Edwin Cuppen; Wigard P Kloosterman
Journal:  Genome Res       Date:  2013-11-12       Impact factor: 9.043

Review 4.  Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological Malignancies.

Authors:  Anna Myriam Perrone; Giulia Girolimetti; Martina Procaccini; Lorena Marchio; Alessandra Livi; Giulia Borghese; Anna Maria Porcelli; Pierandrea De Iaco; Giuseppe Gasparre
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.